U.S. markets closed

ADC Therapeutics SA (ADCT)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
22.21-0.01 (-0.05%)
At close: 4:00PM EDT
Sign in to post a message.
  • S
    Sheriff
    How come this isn't going up at all?
  • A
    Anonymous
    Don't sell your shares! I think the institutional investors, hedge funds, big players, etc are holding down the price.

    Like the other person on this board said, the price should shoot up once the bs clears. That's what I'm hoping for anyways.
  • A
    Anonymous
    Looking like another down market with all futures in the red. I think it will keep going down until all the weak hand are shaken out and all the shares that are hedged or bought on margin are all liquidated, then we may start to see more green/up days going forward.
  • P
    Peter Y
    Why down after approval announcement?
  • A
    Anonymous
    What's happening here. Market green, green, green but ADCT red, red, and red-er. Something wrong? Or, market manipulation?
  • R
    RandallH
    Congrats ADCT fans! Good day for the patients in need and incredible achievement for the company.
  • H
    Hieu
    ADCT here comes the news!!
    Bullish
  • C
    Connor
    Easy buy under $25
    Bullish
  • C
    Chari
    Sell on the news is the typical reaction to FDA approvals these days
  • K
    Kulbir Suri
    Sell on news.
  • c
    chester lipper
    it should go up next week as pricing becomes more clear
  • Y
    Yahoo Finance Insights
    ADC Therapeutics is down 9.26% to 21.66
  • M
    Michael
    After approval, then buy more if it goes down.
  • P
    Peter Y
    No approval is good for this stock? Who are selling shares? Covid 19 patients? Unbelievable!
  • c
    chester lipper
    At this point about one month before the approval date, they should have gone into labeling negotiation with the FDA. Since we have not heard any delays, they should be on time.
  • s
    stocktargetadvisor
    $ADCT
    Reiterated by HC Wainwright Buy USD 57 » USD 55
    Maintains HC Wainwright Buy USD 57 » USD 55
  • Y
    Yahoo Finance Insights
    ADC Therapeutics is up 9.67% to 26.76
  • Y
    Yahoo Finance Insights
    ADC Therapeutics is up 9.59% to 25.48
  • Y
    Yahoo Finance Insights
    ADC Therapeutics is up 8.10% to 24.57
  • P
    Paul
    Surprised it’s so quiet here. Meanwhile the company’s leading drug Lonca is already under FDA review and the response will be given in May...
    Bullish